We found that the trends in the expression of CDH1, IGFBP3, EPCAM, ACTA2, TPM1, ACTC1, and ACTN1 in BC samples containing early-advanced stages were consistent with those in early-stage BC. This evidence concerns the gene EPCAM and breast cancer.